Analysts Set Henry Schein, Inc. (NASDAQ:HSIC) PT at $77.50

Henry Schein, Inc. (NASDAQ:HSIC) has received a consensus recommendation of “Moderate Buy” from the twelve brokerages that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation, five have given a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $77.50.

A number of analysts have issued reports on HSIC shares. JPMorgan Chase & Co. cut their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a report on Monday, August 12th. Evercore ISI boosted their price target on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Robert W. Baird lowered their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 7th. Barrington Research reaffirmed an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a report on Friday, September 20th. Finally, StockNews.com lowered Henry Schein from a “hold” rating to a “sell” rating in a report on Wednesday.

Henry Schein Stock Performance

HSIC opened at $70.64 on Monday. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46. Henry Schein has a 12-month low of $60.01 and a 12-month high of $82.63. The business has a 50 day moving average of $70.62 and a 200-day moving average of $69.78. The stock has a market cap of $9.05 billion, a price-to-earnings ratio of 23.86, a PEG ratio of 2.00 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.01. The company had revenue of $3.10 billion for the quarter, compared to analyst estimates of $3.27 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The company’s revenue was up .0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.31 earnings per share. On average, equities research analysts expect that Henry Schein will post 4.74 earnings per share for the current year.

Insider Buying and Selling at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now directly owns 71,833 shares in the company, valued at approximately $4,978,026.90. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 1.14% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of HSIC. Cromwell Holdings LLC lifted its position in Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after purchasing an additional 170 shares during the last quarter. Summit Securities Group LLC bought a new stake in Henry Schein during the 2nd quarter valued at $31,000. Beach Investment Counsel Inc. PA purchased a new stake in Henry Schein during the 2nd quarter valued at $37,000. Blue Trust Inc. grew its holdings in Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after acquiring an additional 475 shares during the last quarter. Finally, Farther Finance Advisors LLC increased its position in shares of Henry Schein by 58.9% in the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after acquiring an additional 346 shares during the period. 96.62% of the stock is currently owned by institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.